Foyston Gordon & Payne Inc Increases Stock Holdings in Henry Schein, Inc. $HSIC

Key Points

• Foyston Gordon & Payne Inc increased its holdings in Henry Schein, Inc. by 13.7% in the first quarter, now owning 107,948 shares worth approximately $7.39 million.
• Henry Schein reported $1.10 earnings per share for the most recent quarter, missing estimates, while revenue increased by 3.3% year-over-year, totaling $3.24 billion.
• Several analysts have downgraded Henry Schein's stock, with the average rating now at "Hold" and a target price of $75.58, down from previous estimates.

Foyston Gordon & Payne Inc lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 13.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 107,948 shares of the company's stock after acquiring an additional 12,987 shares during the period. Henry Schein accounts for about 1.8% of Foyston Gordon & Payne Inc's portfolio, making the stock its 20th largest position. Foyston Gordon & Payne Inc owned approximately 0.09% of Henry Schein worth $7,393,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Guggenheim Capital LLC grew its stake in shares of Henry Schein by 2.5% in the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after acquiring an additional 159 shares in the last quarter. UMB Bank n.a. grew its stake in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares in the last quarter. Humankind Investments LLC grew its stake in shares of Henry Schein by 7.4% in the 4th quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after acquiring an additional 211 shares in the last quarter. HB Wealth Management LLC grew its stake in shares of Henry Schein by 1.5% in the 1st quarter. HB Wealth Management LLC now owns 15,419 shares of the company's stock worth $1,056,000 after acquiring an additional 226 shares in the last quarter. Finally, J. Safra Sarasin Holding AG grew its stake in shares of Henry Schein by 1.1% in the 4th quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company's stock worth $1,529,000 after acquiring an additional 231 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on HSIC. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research note on Monday, July 14th. Piper Sandler reduced their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday, August 6th. Finally, Robert W. Baird restated a "neutral" rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Four analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $75.58.

Henry Schein Stock Performance

NASDAQ HSIC traded up $0.33 during trading on Wednesday, hitting $68.64. 2,059,320 shares of the company's stock traded hands, compared to its average volume of 1,773,902. The stock has a market capitalization of $8.32 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 2.22 and a beta of 0.81. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The business has a 50 day moving average of $70.67 and a 200-day moving average of $70.61.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period last year, the company earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.